Wednesday, April 7, 2010
Interesting: Why Poland Rejected H1N1 Vaccine
Pharmaceutical companies and governments came under fire at a hearing into the H1N1 flu and vaccine conducted in Paris by European parliamentarians this week, reports the Center for Medical Consumers in this interesting item. The star of the hearing was Dr. Ewa Kopacz, Poland's health minister, who disclosed the secretive and unusual contract terms pharmaceutical firms imposed on governments to sell them the H1N1 flu vaccine.
Poland refused to do a mass vaccination of its citizens because of the onerous terms and doubts about the vaccine's safety, Kopacz said. The country wound up with relatively low flu rates compared to other countries, the item says.
The contract for the vaccine required Poland to pay two to three times more than for regular seasonal flu vaccines, even though the technologies to produce them are the same, Kopacz said. As well, Poland would have had to sign a contract absolving the drug-maker of responsibility for vaccine injuries, she said. Other countries, including Canada and the U.S., agreed to such terms. Click the tag links below for more coverage at this site on H1N1 and the flu vaccine. Also, see these blog posts (here, here and here).